Studying needs of using blood in National Institute of Hematology and Blood Transfusion (04/2005-03/2006)

Background: Blood is a very special product to use for patients treatment. In order to have better plan to supply enough blood and on time according to the needs of clinics, studying to explore the trend, the needs of using blood and its products in clinics are very necessary. Objective: to identify needs using blood and blood products for patients with blood-related diseases at National Institute of Hematology and Blood Transfusion from 4/2005 - 03/2006. Subjects and methods: The retrospective study was carried out on all of the data about using blood and blood products for patients with blood- related diseases about: Name of patient, age, diagnosis. Kind of blood products, blood group, the time using blood and blood products. Result: The trend using of blood and blood products of clinics has increased (increased 1.64 times) from 2,132 units in April 2005 to 3,499 units in March 2006. Blood products are used 100%.T consumption seemed to increase during months at the end and earlier of year, especially March 2006. Red cell concentrate used mostly. 0 blood type was used most often. Conclusion: Identifying needs using blood for patients with blood-related disease in clinics are base in order to National Institute of Hematology and Blood Transfusion has planned to collect, screen and make blood products to assure supplying blood and blood products enough and safety. \r\n', u'\r\n', u'

HCV infection among haemodialysis patients and some subjects who have relationship with blood transfusion in Vietnam

Screening anti- HCV for blood donors has been done in Vietnam since 1995. However up to now, many blood transfusion centers at provincial and district levels still have not been able to screen HCV for blood donors due to lack of equipment and test kits. Besides that, there are a few studies on the more studies on that area, especially for blood donors. In this study, we had identified anti-HCV for four subject groups by using ELISA technique with diagnostic tests of GBC company. The results showed that percentage of anti-HCV positive among donors who had more than one time blood donation at NIHBT is lower than that among first -time blood donors (0.47 vs 1.53) with a statistical significance P<0.01. This difference can be explained that donors who have more than one-time blood donation at NIHBT have been screened for HCV at NIHBT before. On the other hand, prevalence of HCV infection among patients who had received blood many times are very high (more than 50%). It also shows that excluding blood samples with HCV infection is very important

Situation of HIV, HBV, HCV infection among patients with hematologic diseases in the National Institute of Hematology and Blood transfusion during 1998-1999

We identified anti HIV, anti HCV and HBsAg in 397 blood disease patients (160 males: 237 females with their age rank 16-80) were treated in National Institute of Hematology and Blood Transfusion during two year(1998-1999). The results showed that: - The proportion of HBsAg, anti HIV at blood disease patients were: 7.05%; 3.02%; 0.05%, respectively.- The proportion of HbsAg, anti HCV and anti HIV at male and female patients were:+ HBsAg: male: 11.25%; Female: 4.21%+ Anti HCV: male: 3.75%; female: 2.53%+ Anti HIV: male: 0.62%; female: 0.42%. The percentage of anti HCV is highest in hemophilia patients (51.7%).- The percentage of HBsAg is higher in MDS patients (16.2%) and hemolytic patients (14.58%).- The percentage of anti HCV(+) in patients polytransfusion is: 5.6%.- The percentage of anti HCV is highest in Kahler and lymphoma patients (19.04%). -The percentage of HBsAg is higher in MDS patients 15.7%).